Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-16.64	90.87	109.00
Graham Fair Price	0.74	545.77	541.79
PEG	-809.36	-10.41	-1.14
Price/Book	-25.30	4.62	6.18
Price/Cash Flow	inf	0.00	1897.42
Prices/Earnings	-18.66	36.17	44.46
Price/Sales	-23.68	28.22	36.98
Price/FCF	inf	0.00	1897.42
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-6.12	0.44	0.47
Operating Margin	-15.18	0.26	0.31
ROA	-9.18	0.03	0.03
ROE	0.03	0.03	-8.16
ROIC	0.03	0.03	-19.38
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-1.00	1.20	-16.81
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.31	-0.13	58.76
EPS QOQ	-0.39	-0.03	91.05
FCF QOQ	0.04	-1.00	2714.29
Revenue QOQ	-0.20	0.03	-85.86
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	86.84	75.76	-12.76
Days Sales Outstanding (DSO)	98.01	113.21	15.50
Inventory Turnover	1.04	1.19	14.63
Debt/Capitalization	0.00	0.02	100.00
Quick Ratio	3.64	3.70	1.53
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	612.82	644.18	5.12
Cash	354.47	386.82	9.13
Capex	0.00	0.00	0.00
Free Cash Flow	2.00	0.00	inf
Revenue	102.37	105.33	2.89
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	4.38	4.19	-4.27
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-11.06	-13.58	-22.79
Naive Interpretation	Member

06 - Financial Health · Bad

Rating